Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22003
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDalekos, G. N.en
dc.contributor.authorElisaf, M. S.en
dc.contributor.authorPapagalanis, N.en
dc.contributor.authorTzallas, C.en
dc.contributor.authorSiamopoulos, K. C.en
dc.date.accessioned2015-11-24T19:20:00Z-
dc.date.available2015-11-24T19:20:00Z-
dc.identifier.issn0014-2972-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22003-
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAgeden
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectHypertension/drug therapy/*immunologyen
dc.subjectInterleukin-1/*blooden
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectPilot Projectsen
dc.subjectReceptors, Interleukin-2/analysisen
dc.titleElevated interleukin-1 beta in the circulation of patients with essential hypertension before any drug therapy: a pilot studyen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/8911869-
heal.identifier.secondaryhttp://onlinelibrary.wiley.com/store/10.1111/j.1365-2362.1996.tb02141.x/asset/j.1365-2362.1996.tb02141.x.pdf?v=1&t=h0m4gqjp&s=a901534ba932ddfd25a2c12135889b827759693c-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1996-
heal.abstractImmune system disturbances have been implicated in the pathogenesis of essential hypertension. The aim of this study was to determine the levels of the interleukin-1 beta and soluble interleukin-2 receptors in serum samples from 114 hypertensive patients before any drug therapy because there are no well-established data regarding these immunologic mediators in essential hypertension. We found increased levels of interleukin-1 beta in 59.6% of patients, while soluble interleukin-2 receptors were not detected. The interleukin-1 beta levels were significantly higher in patients than in healthy controls (P = 0.0001). We conclude that patients with essential hypertension have high levels of interleukin-1 beta but not indicators of cellular immune activation in their sera. Further studies are in progress in order to confirm, explain and assess the clinical utility of the above findings.en
heal.journalNameEur J Clin Investen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Dalekos-1996-Elevated interleukin.pdf417.82 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons